tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB
US Market

Biogen (BIIB) Technical Analysis

Compare
4,739 Followers

Technical Sentiment

Overall Consensus
Strong Sell
2Bullish
6Neutral
14Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Biogen’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is -3.07, suggesting Biogen is a Buy.
Biogen’s (BIIB) 20-Day exponential moving average is 140.82, while Biogen’s (BIIB) share price is $137.08, making it a Sell.
Biogen’s (BIIB) 50-Day exponential moving average is 147.74, while Biogen’s (BIIB) share price is $137.08, making it a Sell.

Biogen (BIIB) Pivot Points

Feb 22, 2025, 01:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
132.43
133.73
135.20
136.50
137.97
139.27
140.74
Fibonacci
133.73
134.78
135.44
136.50
137.55
138.21
139.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Feb 22, 2025, 01:47 AM
Period
Simple
Exponential
MA5
137.22Sell
137.27Sell
MA10
138.52Sell
138.53Sell
MA20
141.71Sell
140.82Sell
MA50
146.40Sell
147.74Sell
MA100
161.19Sell
160.11Sell
MA200
188.68Sell
181.83Sell
Biogen’s (BIIB) 10-Day exponential moving average is 138.53, while Biogen’s (BIIB) share price is $137.08, making it a Sell.
Biogen’s (BIIB) 100-Day exponential moving average is 160.11, while Biogen’s (BIIB) share price is $137.08, making it a Sell.
Biogen’s (BIIB) stock price is $137.08 and Biogen’s (BIIB) 50-day simple moving average is 146.40, creating a Sell signal.
Biogen’s (BIIB) stock price is $137.08 and Biogen’s (BIIB) 100-day simple moving average is 161.19, creating a Sell signal.
Biogen’s (BIIB) stock price is $137.08 and Biogen’s (BIIB) 200-day simple moving average is 188.68, creating a Sell signal.

Biogen (BIIB) Technical Indicators

Feb 22, 2025, 01:47 AM
Name
Value
Implied Action
RSI (14)
39.57
Neutral
STOCH (9,6)
48.94
Neutral
STOCHRSI (14)
43.40
Neutral
MACD (12,26)
-3.07
Buy
ADX (14)
22.06
Neutral
Williams %R
-54.63
Buy
CCI (14)
-85.70
Neutral
ATR (14)
4.08
-
Ultimate Oscillator
44.09
Neutral
ROC
-6.26
Sell
Biogen’s (BIIB) Relative Strength Index (RSI) is 39.57, creating a Neutral signal.
Biogen’s (BIIB) Trend Strength Indicator (ADX) is 22.06, creating a Neutral signal.
Biogen’s (BIIB) Commodity Channel Index (CCI) is -85.70, creating a Neutral signal.
Biogen’s (BIIB) Price Rate of Change (ROC) is -6.26, creating a Sell signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Strong Sell.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 39.57, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is -3.07, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 137.22, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 141.71, which suggests BIIB is a Sell.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 146.40, which suggests BIIB is a Sell.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 188.68, which suggests BIIB is a Sell.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -54.63, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is -85.70, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis